News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
859,709 Results
Type
Article (87352)
Company Profile (759)
Press Release (771572)
Multimedia
Podcasts (168)
Webinars (28)
Section
Business (233021)
Career Advice (4137)
Deals (39786)
Drug Delivery (134)
Drug Development (91232)
Employer Resources (202)
FDA (18270)
Job Trends (17394)
News (397313)
Policy (39919)
Tag
Academia (3003)
Academic (2)
Accelerated approval (17)
Adcomms (35)
Allergies (123)
Alliances (56979)
ALS (142)
Alzheimer's disease (1670)
Antibody-drug conjugate (ADC) (219)
Approvals (18278)
Artificial intelligence (475)
Autoimmune disease (65)
Automation (25)
Bankruptcy (406)
Best Places to Work (12633)
BIOSECURE Act (22)
Biosimilars (157)
Biotechnology (484)
Bladder cancer (122)
Brain cancer (50)
Breast cancer (469)
Cancer (3736)
Cardiovascular disease (330)
Career advice (3552)
Career pathing (37)
CAR-T (237)
CDC (53)
Cell therapy (661)
Cervical cancer (32)
Clinical research (75189)
Collaboration (1345)
Company closure (4)
Compensation (916)
Complete response letters (59)
COVID-19 (2947)
CRISPR (81)
C-suite (557)
Cystic fibrosis (132)
Data (4117)
Decentralized trials (2)
Denatured (60)
Depression (108)
Diabetes (444)
Diagnostics (7076)
Digital health (35)
Diversity (11)
Diversity, equity & inclusion (49)
Drug discovery (227)
Drug pricing (178)
Drug shortages (36)
Duchenne muscular dystrophy (196)
Earnings (98708)
Editorial (54)
Employer branding (25)
Employer resources (171)
Events (132674)
Executive appointments (975)
FDA (20641)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (5)
Frontotemporal dementia (13)
Funding (1211)
Gene editing (169)
Generative AI (45)
Gene therapy (528)
GLP-1 (1008)
Government (5371)
Grass and pollen (7)
Guidances (335)
Healthcare (20937)
HIV (48)
Huntington's disease (37)
IgA nephropathy (55)
Immunology and inflammation (238)
Immuno-oncology (19)
Indications (51)
Infectious disease (3177)
Inflammatory bowel disease (184)
Inflation Reduction Act (15)
Influenza (92)
Intellectual property (180)
Interviews (815)
IPO (17924)
IRA (59)
Job creations (5196)
Job search strategy (2864)
Kidney cancer (15)
Labor market (74)
Layoffs (634)
Leadership (31)
Legal (10148)
Liver cancer (91)
Longevity (12)
Lung cancer (532)
Lymphoma (256)
Machine learning (27)
Management (66)
Manufacturing (615)
MASH (130)
Medical device (14852)
Medtech (14873)
Mergers & acquisitions (22714)
Metabolic disorders (1126)
Multiple sclerosis (133)
NASH (23)
Neurodegenerative disease (219)
Neuropsychiatric disorders (59)
Neuroscience (2669)
NextGen: Class of 2025 (7687)
Non-profit (5095)
Now hiring (56)
Obesity (551)
Opinion (308)
Ovarian cancer (123)
Pain (160)
Pancreatic cancer (163)
Parkinson's disease (235)
Partnered (28)
Patents (403)
Patient recruitment (295)
Peanut (57)
People (66183)
Pharmaceutical (144)
Pharmacy benefit managers (26)
Phase I (23180)
Phase II (32656)
Phase III (24563)
Pipeline (2605)
Policy (289)
Postmarket research (3554)
Preclinical (10462)
Press Release (72)
Prostate cancer (187)
Psychedelics (51)
Radiopharmaceuticals (281)
Rare diseases (644)
Real estate (7420)
Recruiting (78)
Regulatory (27894)
Reports (64)
Research institute (2688)
Resumes & cover letters (650)
Rett syndrome (13)
RNA editing (15)
RSV (69)
Schizophrenia (131)
Series A (200)
Series B (148)
Service/supplier (30)
Sickle cell disease (79)
Special edition (25)
Spinal muscular atrophy (170)
Sponsored (40)
Startups (4318)
State (2)
Stomach cancer (17)
Supply chain (98)
Tariffs (89)
The Weekly (106)
Vaccines (1027)
Venture capital (66)
Weight loss (387)
Women's health (58)
Worklife (21)
Date
Today (123)
Last 7 days (587)
Last 30 days (2381)
Last 365 days (33698)
2025 (25248)
2024 (38139)
2023 (42568)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1278)
Alabama (80)
Alaska (7)
Arizona (299)
Arkansas (14)
Asia (50883)
Australia (8940)
California (9214)
Canada (2797)
China (863)
Colorado (391)
Connecticut (410)
Delaware (253)
Europe (116927)
Florida (1353)
Georgia (308)
Hawaii (3)
Idaho (67)
Illinois (801)
India (47)
Indiana (447)
Iowa (19)
Japan (303)
Kansas (123)
Kentucky (36)
Louisiana (20)
Maine (76)
Maryland (1249)
Massachusetts (6929)
Michigan (307)
Minnesota (554)
Mississippi (4)
Missouri (116)
Montana (33)
Nebraska (26)
Nevada (106)
New Hampshire (76)
New Jersey (2550)
New Mexico (32)
New York (2516)
North Carolina (1389)
North Dakota (10)
Northern California (4128)
Ohio (287)
Oklahoma (20)
Oregon (50)
Pennsylvania (1919)
Puerto Rico (19)
Rhode Island (46)
South America (1655)
South Carolina (46)
South Dakota (1)
Southern California (3524)
Tennessee (148)
Texas (1443)
United States (34120)
Utah (273)
Virginia (243)
Washington D.C. (82)
Washington State (794)
West Virginia (4)
Wisconsin (95)
Wyoming (1)
There are 859,709 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Spur Therapeutics Presents Updated Phase 1/2 Data on Its Gene Therapy Candidate in Gaucher Disease at ESGCT 32nd Annual Congress
October 7, 2025
·
3 min read
Press Releases
Cellectis to Present Data on Non-Viral Gene Therapy and TALE Base Editors at the ESGCT Annual Congress
October 7, 2025
·
5 min read
Press Releases
Bioxodes appoints industry veteran Philippe Monteyne as chairman as it accelerates late-stage development of breakthrough stroke candidate
October 7, 2025
·
6 min read
Press Releases
Theolytics Appoints Experienced Medical Oncologist Matilde Saggese, MD, as Chief Medical Officer
October 7, 2025
·
3 min read
Press Releases
Blue Earth Therapeutics Presents Modelling Data Supporting Early Dose Intensification of Lutetium (177Lu) rhPSMA-10.1 Injection in mCRPC
October 7, 2025
·
5 min read
Press Releases
MaaT Pharma Announces Positive Second Safety Interim Analysis from DSMB for Phase 2b PHOEBUS Trial Evaluating MaaT033 for Patients Receiving Allo-HSCT
October 7, 2025
·
4 min read
Press Releases
BlueRock Therapeutics reports positive 36-month results from Phase I trial of bemdaneprocel for treating Parkinson’s disease
October 7, 2025
·
8 min read
Press Releases
RIBOMIC Announces Positive Phase 2 Cohort 2 Results for Umedaptanib Pegol in Achondroplasia, Demonstrating an Increase in the Annualized Growth Rate of up to +5.0 cm/year with Biweekly Administration in Children Aged 5 Years and Older
October 7, 2025
·
5 min read
Press Releases
Gain Therapeutics Presents Initial Data from Phase 1b Clinical Study of GT-02287 in Parkinson’s Patients at International Congress of Parkinson’s Disease and Movement Disorders®
October 7, 2025
·
7 min read
Press Releases
MaxCyte Announces Strategic Platform License Agreement with Moonlight Bio to Advance T Cell Therapies for Solid Tumors
October 7, 2025
·
4 min read
1 of 85,971
Next
